1.Markowitz, LE. Preblud, SR, Fine, PEM. Orenstein WA Duration of live measles vaccine-induced immunity. Pediatr Infect Dis. 1990;9:101–110.
2.Measles prevention recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR. 1989;38(S9):1–18.
3.Measles outbreak-New York City, 1990-1991. MMWR. 1991;40(18):305–306.
4.Katz, SL. The politics of measles. Rev Infect Dis. 1991;1:1–2.
5.Measles-United States, 1990. MMWR. 1991; 40(22):369–372.
6.Markowitz, LE, Preblud, SR, Orenstein, WA, et al. Patterns of transmission in measles outbreaks in the United States, 1985 1986. N Engl J Med. 1989;320:75–81.
7.Davis, DM, Orenstein, WA, Frank, JA Jr, et al. Transmission of measles in medical settings. JAMA. 1986;255:1295–1298.
8.Subbarao, EK, Andrews-Mann, L, Amin, S, Greenberg, J, Kumar, ML. Postexposure prophylaxis for measles in a neonatal intensive care unit. J Pediatr. 1990;117:782–785.
9.Reyes, MA, DeBorrero, MFRoa, J, Bergonzoli, G, Saravia, NG. Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J. 1987;6:848–851.
10.Edmonson, MB, Addiss, DG, McPherson, JT, Berg, JL, Circa, SR, Davis, JP. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA. 1990;263:2467–2471.
11.Gustafson, TL, Lievens, AW, Brunell, PA, Moellenberg, RG, Buttery, CMG, Sehulster, LM. Measles outbreak in a fully immunized secondary-school population. N Engl J Med. 1987;316:771–774.
12.Mathias, RG, Meekison, WG, Arcand, TA, Schechter, MT. The role of secondary vaccine failures in measles outbreaks. Am J Public Health. 1989;79:475–478.
13.Hull, HF, Montes, JM, Hays, PC, Lucero, RL. Risk factors for measles vaccine failure among immunized students. Pediatrics. 1985;76:518–523.
14.Welliver, RC, Cherry, JD, Holtzman, AE. Typical, moditied, and atypical measles. An emerging problem in the adolescent and adult. Arch Intern Med. 1977;137:39–41.
15.Cherry, JD, Feigin, RD, Shackelford, PG, Hinthom, DR, Schmidt, RR. A clinical and serologic study of 103 children with measles vaccine failure. J Pediatrics. 1973;82:802–808.
16.Brunell, PA, Gershon, AA, Uduman, SA, Steinberg, S. Varicellazoster immunoglobulins during varicella, latency, and zoster. J Infect Dis. 1975;132:49–54.
17.Addiss, DG, Berg, JL, Davis, JP. Revaccination of previously vaccinated siblings of children with measles during an outbreak. J Infect Dis. 1988;157:610–611.
18.Christenson, B, Bottiger, M. Methods for screening the naturally acquired and vaccine-induced immunity to the measles virus. Biologicals. 1990;18:207–211.
19.Chen, RT, Markowitz, LE, Albrecht, P, et al. Measles Ab: reevaluation of protective titers. J Infect Dis. 1990;162:1036–1042.
20.Neumann, Pw, Weber, JM, Jessamine, AG, O'Shaughnessy, MV. Comparisonof measlesantihemolysintest, enzyme-linkedimmunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbial. 1985;22:296–298.
21.Cherry, JD, Feigin, RD, Lobes, LA Jr., et al. Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study. J Pediatrics. 1972;81:217–230.
22.Nagy, G, Kosa, S, Takatsy, S, Koller, M. The use of IgM tests for analysis of the causes of measles vaccine failures: experience gained in an epidemic in Hungary in 1980 and 1981. J Med Virol. 1984:12:93–103.